Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PSO +4.4%, CSX +2.5%, HBAN +1.8%, FITB +1.7%, WAFD +1.3%, SFNC +1.1%, TFC +1.1%, CMA +0.9%, RF +0.5%, AXP +0.5%
Other news:
- KZR +42.7% (regulatory update on Zetomipzomib program)
- IRON +9.2% (receipt of FDA Commissioner's National Priority Voucher for Bitopertin)
- RVMD +7.4% (Daraxonrasib (RMC-6236) awarded voucher from FDA under Commissioner's National Priority Voucher Pilot Program)
- CTEV +7.2% (renews contracts)
- PRAX +5.7% (prices $525 mln offering consisting of common stock and warrats)
- EBC +4.5% (election deadline for merger and anticpated delisting of HarborOne (HONE)
- FIBK +4.1% (Security First bank to acquire branches from First Interstate Bank)
- REFI +3.2% (directors and officers disclose open market stock purchases)
- IONQ +2% (filed prospectus supplement to the prospectus included in the Company's registration statement on Form S-3ASR filed with the SEC on February 26, 2025 covering the resale by certain selling stockholders of an aggregate of 6,649,263 shares)